Latest debt-to-equity ratio
Amphastar Pharmaceuticals Debt-to-equity ratio
Direct answer
Amphastar Pharmaceuticals's debt-to-equity ratio is 89.61%.
The verified market snapshot reports 89.61%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 28, 2026.
Get free Amphastar Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 89.61%
Explore related company data
View Amphastar Pharmaceuticals's market capitalizationView Amphastar Pharmaceuticals's p/e ratioView Amphastar Pharmaceuticals's price-to-book ratioView Amphastar Pharmaceuticals's return on equityView Amphastar Pharmaceuticals's 52-week price rangeView Amphastar Pharmaceuticals's revenue growthView Amphastar Pharmaceuticals's profit marginView all Amphastar Pharmaceuticals key metricsReturn to Amphastar Pharmaceuticals profile